Abeona Therapeutics (ABEO) Total Liabilities (2010 - 2026)

Abeona Therapeutics' Total Liabilities history runs 17 years deep, the most recent figure standing at $53.6 million for Q1 2026.

• On a quarterly basis, Total Liabilities fell 7.61% year-over-year to $53.6 million in Q1 2026; TTM through Mar 2026 was $53.6 million, a 7.61% decrease from a year earlier, with the FY2025 full-year figure at $60.4 million, down 7.0% from the prior year.
• Total Liabilities slipped to $53.6 million in Q1 2026 per ABEO's latest filing, from $60.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $83.7 million in Q1 2024 and bottomed at $23.3 million in Q3 2022.
• The 5-year median for Total Liabilities is $53.6 million (2026), against an average of $51.8 million.
• Across the five-year window, Total Liabilities tumbled 49.56% in 2022 and soared 141.9% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $37.5 million in 2022, then soared by 31.3% to $49.2 million in 2023, then jumped by 31.97% to $64.9 million in 2024, then retreated by 7.0% to $60.4 million in 2025, then retreated by 11.27% to $53.6 million in 2026.
• Per Business Quant, the three latest ABEO Total Liabilities figures stand at $53.6 million (Q1 2026), $60.4 million (Q4 2025), and $59.9 million (Q3 2025).